Abiopharma

Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering

The New York Times Company Declares Regular Quarterly Dividend

BeOne Medicines的基礎血液學產品線在EHA 2026上引領B細胞癌症創新新時代

Il franchising ematologico di base di BeOne Medicines guida la prossima era dellinnovazione oncologica delle cellule B allEHA 2026

Abbott declares 410th consecutive quarterly dividend

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm, Encourages Zillow Group, Inc. (Z, ZG) Shareholders To Inquire About Securities Fraud Class Action

De toonaangevende hematologie-divisie van BeOne Medicines luidt op EHA 2026 een nieuw tijdperk in voor innovatie op het gebied van B-celkanker

Law Offices of Howard G. Smith Encourages Grail, Inc. (GRAL) Shareholders To Inquire About Securities Fraud Class Action

Truqap approved in US for prostate cancer

JEF NOTICE: Investigation Launched into Jefferies Financial Group Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm